METHODS AND APPLICATIONS OF INHIBITORS OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN, TYPE 9 (PCSK9) Russian patent published in 2017 - IPC A61K39/395 A61K31/4745 A61K31/7088 A61K38/17 A61P29/00 

Abstract RU 2636820 C2

FIELD: medicine.

SUBSTANCE: proprotein convertase subtilisin/kexin 9 (PCSK9) is administered to a subject in need thereof, wherein the PCSK9 inhibitor is an antibody or an antigen-binding fragment thereof. Also, PCSK9 application is proposed for manufacture of a medicament for sepsis or septic shockr treatment. A pharmaceutical composition and a commercial package containing the PCSK9 inhibitor.

EFFECT: possibility of treatment of a patient with sepsis or septic shock at doses suitable for intensive care.

21 cl, 5 dwg, 7 tbl

Similar patents RU2636820C2

Title Year Author Number
PCSK9 ANTAGONISTS 2009
  • Ljan Khun
  • Abdich Jasmina Noubija
  • Chaparro Riggers Khav'Er
  • Fernando Gomes Brjus Charl'Z
  • Khokinz Dzhuli Dzhija Li
  • Ponz Khaume
  • Tsju Sjajan
  • Strop Pavel
  • Vang Jujli
RU2528735C2
PCSK9 ANTAGONISTS 2014
  • Lyan Khun
  • Abdich Yasmina Noubiya
  • Chaparro Riggers Khaver Fernando
  • Gomes Bryus Charlz
  • Khokinz Dzhuli Dzhiya Li
  • Ponz Khaume
  • Tsyu Syayan
  • Strop Pavel
  • Vang Yujli
RU2618869C2
PCSK9 VACCINES 2015
  • Galabofa Gergana
  • Shtafler Gyunter
  • Brunner Silviya
  • Vinzauer Gabriele
  • Mairkhofer Andreas
  • Yuno Klaudia
RU2698971C2
METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION 2012
  • Demopulos Gregori A.
  • Dadler Tom
  • Shveble Khans-Vilkhelm
RU2662563C2
METHOD FOR TREATING DISSEMINATED INTRAVASCULAR COAGULATION BY INHIBITING MASP-2 DEPENDENT COMPLEMENT ACTIVATION 2010
  • Shveble Khans-Vilgelm
  • Dadler Tomas A.
  • Tedford Klark I
  • Perent Dzhejms B.
  • Demopulos Gregori A.
RU2600876C2
COMPOSITION FOR MODULATION OF CELL ADHESION MOLECULE EXPRESSION 2007
  • Ehdejr Charl'Z Dehvid
  • Van Jujpin
RU2503463C2
ANTI-PCSK9 ANTIBODY AND ITS APPLICATION 2016
  • Wu Hai
  • Chen Bo
  • Feng Hui
  • Yao Sheng
  • Yao Jian
  • Liu Hongchuan
  • Zhang Libo
  • Zhang Jing
  • Meng Dan
RU2756012C2
METHOD FOR PREDICTING THE RISK OF DEVELOPING CORONARY HEART DISEASE BASED ON GENETIC TESTING DATA 2021
  • Meshkov Aleksej Nikolaevich
  • Kiseleva Anna Vitalevna
  • Ershova Aleksandra Igorevna
  • Zharikova Anastasiya Aleksandrovna
  • Ramenskij Vasilij Evgenevich
  • Sotnikova Evgeniya Andreevna
  • Vyatkin Yurij Viktorovich
  • Drapkina Oksana Mikhajlovna
RU2762958C1
ANTIBODIES WITH PH-DEPENDENT ANTIGEN BINDING 2011
  • Pons Dzhom
  • Chehbot Dzheffri Rehjmond
  • Chaparro Ridzhers Khav'Er Fernando
  • Gomes Brjus Charl'Z
  • Ljan Khon
  • Majavala Kapil
  • Mettetal' Vtoroj Dzherom Tomas
  • Radzhpal Arvind
  • Shelton Dehvid L'Juis
RU2570729C2
METHODS OF TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION 2012
  • Demopulos, Gregory, A.
  • Dudler, Tom
  • Schwaeble, Hans-Wilhelm
RU2743409C2

RU 2 636 820 C2

Authors

Uollej Kit R.

Bojd Dzhon Kh.

Rassel Dzhejms A.

Dates

2017-11-28Published

2013-05-17Filed